Table 3 Initial and highest dose of quetiapine and risperidone: A) patients with BD, B) patients without BD
A) | |||||
Quetiapine (N = 3927) | Risperidone (N = 2108) | ||||
Strength | Initial Dose (n, %) | Highest Dose (n, %) | Strength | Initial Dose (n, %) | Highest Dose (n, %) |
25 mg | 2904 (74.0%) | 2050 (52.2%) | < .5 mg | 978 (46.4%) | 648 (30.7%) |
50 mg | 726 (18.5%) | 1155 (29.4%) | .5 mg | 762 (36.2%) | 842 (39.9%) |
100 mg | 192 (4.9%) | 497 (12.7%) | .6–.9 mg | 0 | 0 |
150 mg | 16 (.4%) | 28 (.7%) | 1 mg | 302 (14.3%) | 492 (23.3%) |
200 mg | 58 (1.5%) | 97 (2.5%) | 1.1–1.9 mg | 0 | 0 |
300 mg | 19 (.5%) | 75 (1.9%) | 2 mg | 43 (2.0%) | 79 (3.8%) |
400 mg | 12 (.3%) | 25 (.6%) | > 2 mg | 23 (1.1%) | 47 (2.2%) |
B) | |||||
Quetiapine (N = 5802) | Risperidone (N = 2835) | ||||
Strength | Initial Dose (n, %) | Highest Dose (n, %) | Strength | Initial Dose (n, %) | Highest Dose (n, %) |
25 mg | 4218 (72.7%) | 3509 (60.5%) | < .5 mg | 1209 (42.6%) | 928 (32.7%) |
50 mg | 1041 (17.9%) | 1422 (24.5%) | .5 mg | 1054 (37.2%) | 1117(39.4%) |
100 mg | 314 (5.4%) | 526 (9.1%) | .6–.9 mg | 0 (0%) | 0 |
150 mg | 34 (.6%) | 56 (1.0%) | 1 mg | 429 (15.1%) | 591 (20.9%) |
200 mg | 98 (1.7%) | 149(2.6%) | 1.1–1.9 mg | 0 | 0 |
300 mg | 72 (1.2%) | 94(1.6%) | 2 mg | 83 (2.9%) | 107 (3.8%) |
400 mg | 25 (.4%) | 46 (.8%) | > 2 mg | 60 (2.1%) | 92 (3.2%) |